Industry
- Life Sciences
Patient-centered Care Models Taking Center Stage in Life Sciences
In this article
In this article
A global leader
QIAGEN is a global leader in delivering best-in-class samples to insight solutions to more than 500,000 customers worldwide.
The company has steadily fueled business growth and expanded its global footprint through consistent M&As across geographies.
Integrate and merge
As a long-term strategic partner, TCS played an instrumental role in helping QIAGEN integrate and merge with other organizations seamlessly, by leveraging TCS’ presence in the region with onsite personnel and resources.
Together, TCS and QIAGEN co-innovated and explored over 150 innovative ideas and digitized key IT and business processes, that helped reimagine and optimize IT service delivery. This brought QIAGEN’s IT infrastructure closer to its 4,700 employees across 35 countries.
Securing network
Driven by the success of the initial engagement, QIAGEN decided to entrust TCS’ security operations center with the task of protecting its global asset network against both internal and external threats, 24x7.
As a result of the positive outcomes, QIAGEN relies on TCS as a strategic partner and is planning to extend the service contract for five more years. In addition to IT services, TCS continues to provide non-IT services in other areas, such as research and development (R&D), human resources, finance, legal, and the like.
Adding value
While reflecting on how well the TCS-QIAGEN collaboration has shaped up over the last few years, Jonathan mentions that it has been an amazing journey, and it is difficult to continue differentiating between the two partners.
TCS’ extensive domain knowledge has been critical for bringing value to the business and ensuring that the 500,000 customers of QIAGEN experience the best that the company has to offer.
What Made it happen
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
Contact
Contact
